RARRES2 and adrenal cortex carcinoma: The downregulation of chemerin expression in malignant adrenocortical carcinoma [197] and acute myeloid leukemia [198] could be assumed as a survival tactic of the cancer cells to evade the immunosuppressive effect of chemerin.